Literature DB >> 16477418

Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia.

Nicolas Boussekey1, Olivier Leroy, Serge Alfandari, Patrick Devos, Hugues Georges, Benoit Guery.   

Abstract

OBJECTIVES: Procalcitonin (PCT) kinetics is a good prognosis marker in infectious diseases, but few studies of community-acquired pneumonia (CAP) have been performed in intensive care units (ICU). We analyzed the relationship between PCT kinetics and outcome in ICU patients with severe CAP. DESIGN AND
SETTING: Prospective observational study in a 16-bed university hospital ICU. PATIENTS: 100 critically ill patients with community-acquired pneumonia. MEASUREMENTS AND
RESULTS: Median PCT was 5.2 ng/ml on day 1 and 2.9 ng/ml on day 3. It increased from day 1 to day 3 in nonsurvivors but decreased in survivors. In multivariate analysis four variables were associated with death: invasive ventilation (odds ratio 10-), multilobar involvement (5.6-), LOD score (6.9-), and PCT increase from day 1 to day 3 (4.5-). In intubated patients with a PCT level below 0.95 ng/ml on day 3 the survival rate was 95%.
CONCLUSION: Increased PCT from day 1 to day 3 in severe CAP is a poor prognosis factor. A PCT level less than 0.95 ng/ml on day 3 in intubated patients is associated with a favorable outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477418     DOI: 10.1007/s00134-005-0047-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

Authors:  S Harbarth; K Holeckova; C Froidevaux; D Pittet; B Ricou; G E Grau; L Vadas; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

2.  Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates.

Authors:  Roxane Claeys; Stephanie Vinken; Herbert Spapen; Kristien ver Elst; Katelyn Decochez; Luc Huyghens; Frans K Gorus
Journal:  Crit Care Med       Date:  2002-04       Impact factor: 7.598

3.  Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis.

Authors:  A Polzin; M Pletz; R Erbes; M Raffenberg; H Mauch; S Wagner; G Arndt; H Lode
Journal:  Eur Respir J       Date:  2003-06       Impact factor: 16.671

4.  Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis.

Authors:  Ville Pettilä; Marja Hynninen; Olli Takkunen; Pentti Kuusela; Matti Valtonen
Journal:  Intensive Care Med       Date:  2002-07-19       Impact factor: 17.440

5.  Diagnostic and prognostic value of procalcitonin in patients with septic shock.

Authors:  Christophe Clec'h; Françoise Ferriere; Philippe Karoubi; Jean P Fosse; Michel Cupa; Philippe Hoang; Yves Cohen
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

Review 6.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

Authors:  Liliana Simon; France Gauvin; Devendra K Amre; Patrick Saint-Louis; Jacques Lacroix
Journal:  Clin Infect Dis       Date:  2004-07-02       Impact factor: 9.079

7.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

8.  Comparison of procalcitonin and C-reactive protein as markers of sepsis.

Authors:  Aldo Luzzani; Enrico Polati; Romolo Dorizzi; Alessio Rungatscher; Raffaella Pavan; Alberto Merlini
Journal:  Crit Care Med       Date:  2003-06       Impact factor: 7.598

9.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

10.  Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit.

Authors:  N Boussekey; O Leroy; H Georges; P Devos; T d'Escrivan; B Guery
Journal:  Infection       Date:  2005-08       Impact factor: 3.553

View more
  32 in total

1.  Polymorphism rs2239185 in vitamin D receptor gene is associated with severe community-acquired pneumonia of children in Chinese Han population: a case-control study.

Authors:  Wei Li; Linying Guo; Hongri Li; Chunrong Sun; Xiaodai Cui; Guowei Song; Jianhua Wang; Qi Zhang
Journal:  Eur J Pediatr       Date:  2014-11-01       Impact factor: 3.183

2.  Comparison of serum procalcitonin in respiratory infections and bloodstream infections.

Authors:  Yanhui Zhu; Yulin Yuan; Huayi Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

Review 4.  Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

Authors:  Deirdre Morley; Antoni Torres; Catia Cillóniz; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

5.  Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia.

Authors:  A Lacoma; N Rodríguez; C Prat; J Ruiz-Manzano; F Andreo; A Ramírez; A Bas; M Pérez; V Ausina; J Domínguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-26       Impact factor: 3.267

6.  Procalcitonin and pneumonia: is it a useful marker?

Authors:  Mirjam Christ-Crain; Beat Müller
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

7.  Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.

Authors:  Stefan Krüger; Santiago Ewig; Jana Papassotiriou; Jan Kunde; Reinhard Marre; Heike von Baum; Norbert Suttor; Tobias Welte
Journal:  Respir Res       Date:  2009-07-12

8.  Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission.

Authors:  B Suberviola; A Castellanos-Ortega; A Ruiz Ruiz; M Lopez-Hoyos; M Santibañez
Journal:  Intensive Care Med       Date:  2013-08-16       Impact factor: 17.440

9.  Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.

Authors:  Stefan Krüger; Jana Papassotiriou; Reinhard Marre; Klaus Richter; Christian Schumann; Heike von Baum; Nils G Morgenthaler; Norbert Suttorp; Tobias Welte
Journal:  Intensive Care Med       Date:  2007-10-16       Impact factor: 17.440

10.  Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome.

Authors:  Pierre Emmanuel Charles; Claire Tinel; Saber Barbar; Serge Aho; Sébastien Prin; Jean Marc Doise; Nils Olivier Olsson; Bernard Blettery; Jean Pierre Quenot
Journal:  Crit Care       Date:  2009-03-16       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.